Ad
related to: yale new haven cancer- Screen Heart Problems
Help Prevent Heart Disease with
KP's Specialized Treatment & Care.
- Cardiac Treatment
Get High-Quality Cardiac Treatment
With KP's Passionate Doctors.
- Detect Cancer Early
Learn About Our Rigorous Screening
To Find And Treat Cancer Early.
- Cardiac Research
Receive Care That Is Backed
By The Latest Advances In Science.
- Screen Heart Problems
Search results
Results from the WOW.Com Content Network
Yale Cancer Center (YCC) was founded in 1974 as a result of an act of Congress in 1971, which declared the nation's "war on cancer ". It is one of a network of 56 Comprehensive Cancer Centers designated by the National Cancer Institute (NCI). Currently directed by Dr. Eric Winer, [1] the Cancer Center brings together the resources of the Yale ...
Yale New Haven Hospital (YNHH) is a 1,541-bed hospital located in New Haven, Connecticut. [1] It is the second-largest hospital in the United States [2] and one of the largest in the world. It is the primary teaching hospital for the Yale School of Medicine and the Yale School of Nursing. Owned and operated by the Yale New Haven Health System ...
Eric Winer. Eric P. Winer (born 1956) is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital Yale New Haven Health System, effective February 1, 2022. [1] He also is Deputy Dean for Cancer Research at Yale School of Medicine.
Vincent Theodore DeVita Jr. (born March 7, 1935) is the Amy and Joseph Perella Professor of Medicine at Yale Cancer Center, and a Professor of Epidemiology and Public Health. He directed the Yale Cancer Center from 1993 to 2003. [1] He has been president of the board of directors of the American Cancer Society (2012-2013).
Yale New Haven Health System. Yale New Haven Health System (YNHHS) is a nonprofit healthcare system with headquarters in New Haven, Connecticut. [1] It is Connecticut's largest healthcare system with 2,409 beds [2] and includes hospitals, physicians and related health services throughout Connecticut as well as New York and Rhode Island. [3]
In 1926, Yale-New Haven Hospital became the first to set up a cancer registry. In 1956, the American College of Surgeons (ACoS) formally adopted a policy to encourage, through their Approvals Program, the development of hospital-based cancer registries. In 1973, the Surveillance, Epidemiology and End Results (SEER) Program of NCI established ...
Roy S. Herbst. Roy S. Herbst (born January 16, 1963) is an American oncologist who is the Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.
He later managed the Adult Leukemia Service at Yale University and served as the Chief Clinical Officer of the Yale New Haven Hospital Cancer Center. Marks joined the Center for Biologics Evaluation and Research as deputy director in 2012, and was promoted to director in 2016.
Ad
related to: yale new haven cancer